Fujitsu and Daiichi Life Group Launch Joint Research to Advance Asset Management with Quantum Technology JCN Newswire

Fujitsu and Daiichi Life Group Launch Joint Research to Advance Asset Management with Quantum Technology

Kawasaki and Tokyo, Japan, June 4, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and Daiichi Life Group, Inc. today announced that they conduct joint research from April 2026 to March 2027 to advance asset management operations through the application of quantum technology in the insurance sector.This joint research will leverage the expertise of Daiichi Life Insurance Co., Ltd., a leading institutional investor in Japan managing approximately 30 trillion yen in assets, by addressing practical challenges in its asset management operations. Both companies will jointly design and develop quantum algorithms to optimize asset allocation across multiple asset classes, such as stocks, bonds, and alternative assets, considering risk-return balance and liability characteristics. They will also conduct performance verification using quantum computer simulators [1] (quantum simulators) and quantum computers.When making asset allocation decisions, it is necessary to simultaneously consider complex factors such as the balance between risk and return, liability characteristics, regulatory requirements, and investment constraints for each asset class. The two companies aim to conduct more comprehensive and efficient evaluations that take these factors into account under a wide range of economic scenarios, with the goal of researching and analyzing optimal asset allocation strategies.BackgroundIn recent years, advanced technologies such as AI and quantum technology have the potential to bring about transformation in various sectors of society. Particularly in the financial industry, these technologies are expected to enable more sophisticated risk analysis, improved customer experience, and enhanced operational efficiency, which were not achievable with conventional computers.Convinced that quantum computers are a key technology that will bring about revolutionary changes in society and business, Fujitsu is actively engaged in the research and development of quantum technology and is promoting its social implementation through joint verification with companies across various industries, with a view to practical application.Daiichi Life Group is working to enhance its cross-group IT and digital capabilities, aiming to leverage rapidly advancing cutting-edge technologies as a driving force for business growth as it strives to become an “global top-tier insurance group” and a “leader shaping the future of Japanese insurance industry.” Furthermore, Daiichi Life Insurance manages approximately 30 trillion yen in assets. If portfolio returns were to improve by even +1 basis point (1/10,000) through optimization, this would result in a return improvement of +3 billion yen (30 trillion yen × 1 basis point).Against this backdrop, the two companies have entered into a joint research partnership to accelerate the societal implementation of quantum technology in the insurance sector.Overview of the Joint Research1. Period:April 2026 to the end of March 2027 (planned)2. Verification Details:Both companies will develop technology for optimizing asset allocation patterns using quantum algorithms. By evaluating performance while varying constraints and simulation scenarios using quantum simulators and quantum computers, they will conduct pioneering verification of the effectiveness of asset allocation in asset management operations when utilizing future large-scale, high-performance quantum computers.3. Roles of Both CompaniesFujitsu: Provide expertise and technology related to quantum algorithms, and offer quantum computing environments such as large-scale quantum simulators consisting of 1,024 nodes and quantum computers.Daiichi Life Group:Designs research themes, defines evaluation metrics, and provides asset management data, business workflows, and on-site challenges (through Daiichi Life Insurance's practical operations).Future PlansThe two companies will explore the development of quantum technologies that can be widely applied not only to asset management but also to the insurance sector in the future. Anticipating progress in the practical application of quantum computers, they aim to rapidly deploy these technologies in business once large-scale quantum computers become a reality by conducting practical verification from an early stage. Furthermore, they will contribute to academic advancement and global technological progress by widely disseminating the insights gained through this joint research via academic papers and other publications.[1] Quantum computer simulator:A 40-qubit state-vector quantum computer simulator comprising 1,024 "FX700" supercomputers equipped with "A64FX" processors.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 100,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.5 trillion yen (US$23 billion) for the fiscal year ended March 31, 2026 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuAbout Daiichi Life GroupDaiichi Life Group has built trust with stakeholders since its founding in 1902 as Japan’s first mutual life insurance company, while pursuing key transformations such as its demutualization in 2010 and transition to a holding company structure in 2016. In response to a rapidly changing environment, it defined its Purpose in 2024: “Partnering with you to build a brighter and more secure future,” and aims to deliver broader value beyond traditional life insurance as an insurance and related services provider. In April 2026, the Group changed its corporate name to Daiichi Life Group, Inc. and renewed its global brand as “Daiichi Life.” Looking ahead, it strives to become a global top-tier insurance group and a leader shaping the future of Japanese insurance industry by fiscal 2030. Find out more: Daiichi Life Group, Inc.Press ContactsFujitsu LimitedPublic, Investor and Analyst Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
780万吨碳排放的“超级碗”:当FIFA的绿色承诺撞上北美大陆的物理距离 Latest News

780万吨碳排放的“超级碗”:当FIFA的绿色承诺撞上北美大陆的物理距离

2024年12月13日,瑞士苏黎世国际足联总部,2026年世界杯欧洲区预选赛抽签仪式上的世界杯冠军奖杯。—Dursun Aydemir—Getty Images (SeaPRwire) - Greenly的联合创始人亚历克西斯·诺曼德说得直接:“活动越大,人越多,飞到不同场馆的人就越多,排放就越高。这就是美加墨世界杯将基本成为‘破纪录者’(排放者)的原因,观众人数将是上届的近三倍,而且他们要在更远的距离间穿梭。” [官方发布事实]:国际足联承诺在联合国《体育促进气候行动框架》下,到2030年减排50%,2040年实现碳中和。其2026年可持续发展战略涵盖了能效、废物和物流。对于观众旅行,战略表示将“鼓励相关实体建立缩短距离的高效航空路线”。国际足联未在发稿前回应《时代》周刊的置评请求。 [行业潜文本]:但该战略没有为赛事设定具体的碳目标。碳核算平台Greenly的独立评估给出了冰冷数字:2026年世界杯可能产生780万公吨二氧化碳,是2022年卡塔尔世界杯官方报告排放量的两倍多,相当于塞拉利昂一年的排放。其中87%的排放预计来自观众旅程,而非场馆或物流。尽管国际观众可能只占观众总数的35%,却将产生74%的旅行相关排放。 [官方发布事实]:2026年赛事在部分类别上碳强度确实低于2022年。卡塔尔新建了七个体育场,基础设施占其总碳足迹的24.6%。而2026年赛事将使用许多现有场馆,该比例降至3.1%。美国酒店的碳强度也大约只有卡塔尔的六分之一,后者依赖持续的工业空调对抗沙漠高温。 [行业潜文本]:但这无法抵消规模扩张带来的巨量排放。2022年世界杯就曾因虚假宣传“碳中和”而遭批评。按国际足联自己(被许多监督机构认为低估了的)的计算,其排放达380万公吨,超过冰岛当年全年排放。2026年的预估排放再翻一番。巴黎利用2024奥运会升级城市基础设施、为本地居民预留门票以减少外来游客的案例,成了鲜明的对照。诺曼德称之为“用于升级未来净零经济基础设施的马歇尔计划”,但前提是“你必须真正思考这个问题”。 供应链的真相是,当赛事的经济规模与地理尺度绑定,任何局部的绿色改进在航空燃油的绝对消耗面前都显得苍白。国际足联的减排承诺与赛事扩张的商业逻辑之间,存在一道北美大陆尺度的裂缝。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
“Making Children and Adults Smile:” Honda Launches the SMILE RIDER PROJECT JCN Newswire

“Making Children and Adults Smile:” Honda Launches the SMILE RIDER PROJECT

Suzuka City, Japan, June 4, 2026 - (JCN Newswire via SeaPRwire.com) - Honda will launch the SMILE RIDER PROJECT, a new initiative with Sanrio Co., Ltd. (Sanrio) aimed at communicating the appeal of motorcycles, motorsports, and the importance of road safety to people of all ages.Honda and Sanrio have previously collaborated on motorcycles and parts featuring Sanrio characters. Building on those efforts, the two companies are launching a joint project under the concept of “Making Children and Adults Smile.” By combining the strengths of both companies, the project will work to expand interest in motorcycles and motorsports among younger generations.In addition, Honda promotes its global safety slogan, “Safety for Everyone”*1, with the goal of realizing a society free from traffic collisions for all road users. Through this project, Honda will continue road safety education activities not only for riders and drivers, but also for elementary school students who will become future participants in traffic society. As one of the project's key activities, SANRIO CHARACTERS × Honda Kumamoto Racing will participate in the 2026 FIM*2 Endurance World Championship “Coca-Cola” Suzuka 8 Hours Endurance Road Race 47th Edition (Suzuka 8 Hours), to be held at Suzuka Circuit in Mie Prefecture on Sunday, July 5.For this collaboration, the Honda Ryokuyokai Kumamoto Racing comprised of employees from Kumamoto Factory - Honda’s domestic motorcycle manufacturing base-will be supporting the project. This is to mark the factory’s 50th anniversary since beginning of its operation in 1976 as well as in recognition of the CBR1000RR-R FIREBLADE Suzuka 8 Hours racing model which is developed and manufactured in Kumamoto, Japan.The racing bike will feature special livery inspired by Sanrio’s popular character Kuromi. In addition, Hello Kitty, Kuromi, and Pompompurin will appear on helmets, racing suits, team wear, and inside the pit area, bringing colorful Sanrio character themes to the circuit.Through these activities, Honda aims to attract new audiences to motorcycles and motorsports.*1 A vision of creating a society free from traffic collisions where everyone who uses the road can travel safely, whether driving, riding, cycling, or walking.*2 FIM: Fédération Internationale de Motocyclisme (International Motorcycling Federation).To offer more fans the opportunity to experience the excitement and atmosphere of the Suzuka 8 Hours firsthand, the companies will offer 150 SMILE RIDER PROJECT Supporter Seats. The package includes reserved V2 grandstand seating overlooking Suzuka Circuit’s home straight, providing excellent views of the race start, finish, and pit works, along with exclusive supporter items including a commemorative baseball jersey and support flag created for the project.Tickets will go on sale through Mobility Station, Suzuka Circuit’s official online ticketing service, at 11:00 on June 8 (JST)In addition, the “16–23 ZERO Yen Pass“ for visitors aged 16 to 23 will also offer a SMILE RIDER PROJECT support flag.*3 Through this initiative, more fans will have the opportunity to support SANRIO CHARACTERS × Honda Kumamoto Racing and experience the excitement of motorcycle racing firsthand at Suzuka Circuit.At the Honda RACING Gallery inside Suzuka Circuit Park, visitors can also enjoy a special exhibition featuring past Honda vehicles created in collaboration with Sanrio characters, character greeting events, and limited-edition collaboration merchandise. The exhibition is designed to be enjoyed not only by racing fans, but also by Sanrio character fans.*3 Support flags are available in limited quantities and will be distributed on a first-come, first-served basis while supplies last.For more information about SANRIO CHARACTERS × Honda Kumamoto Racing, please visit: URL https://global.honda/en/motorcycle/SmileRiderProject/For details about the SMILE RIDER PROJECT support seats, please refer to the Suzuka Circuit official website. URL https://www.suzukacircuit.jp/8tai/ticket/fan-seat/ (Japanese)Another key objective of the project is to promote road safety awareness among elementary school students.Since 1970, Honda has actively conducted road safety education activities through its Traffic Safety Planning Department, targeting not only drivers and riders but also children, senior citizens, and all members of traffic society.Statistics show that seven-year-old children account for the highest number of pedestrian traffic casualties by age group*4. In response, Honda will work with the City of Suzuka, including its Board of Education and Traffic Security Division, to distribute Road Safety T-shirts featuring Sanrio characters and road safety messages to approximately 1,400 first-grade students across 28 elementary schools in Suzuka City.A presentation ceremony for the T-shirts is scheduled to take place at a Suzuka elementary school on June 24.Suzuka City will also hold road safety class at elementary school in Suzuka City using educational materials developed by Honda, including Ayatorii*5 Hiyoko and the Digital traffic Safety Karuta, providing opportunities for children to learn about traffic safety and develop greater awareness.Through these initiatives, the project aims to help create the kind of traffic society envisioned by the SMILE RIDER PROJECT—one where children and adults alike can smile.*4 Source: Institute for Traffic Accident Research and Data Analysis (ITARDA), 2015.*5 Ayatorii is derived from the Japanese phrase meaning “explaining safety simply to help people understand.” Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
SnowValley Secures New Partnerships Across Major Global Food Exhibitions in H1 2026, Steadily Expanding Its International Business ACN Newswire

SnowValley Secures New Partnerships Across Major Global Food Exhibitions in H1 2026, Steadily Expanding Its International Business

Zhangjiakou, China, June 4, 2026 - (ACN Newswire via SeaPRwire.com) - In the first half of 2026, SnowValley, China's leading frozen potato product manufacturer, showcased its products and solutions at 4 of the world's premier food industry events — Gulfood in the Middle East, FOODEX Japan, FHA Food & Beverage in Singapore, and THAIFEX-Anuga Asia in Thailand. Through its presence at these flagship exhibitions, SnowValley further strengthened its reach across key consumer markets in the Middle East, East Asia, and Southeast Asia.Leveraging these world's top food industry exhibitions, SnowValley showcased its integrated industrial chain competitiveness and global service capabilities, attracting widespread attention from industry professionals, international buyers, and leading media worldwide.Recognized for multiple consecutive years among the Top 500 Chinese Brands and Top 500 Asian Brands, SnowValley continues to strengthen its international brand presence through its localized market strategies and deep engagement with overseas distribution networks across multiple countries. By securing a series of cross-border strategic partnerships, the company is further expanding its worldwide network and reinforcing its position in the global frozen potato products industry.Throughout the exhibitions, SnowValley earned strong recognition and trust from global buyers by leveraging its highly standardized manufacturing system, market-driven product customization capabilities, and efficient & reliable global supply chain. Today, SnowValley offers a portfolio of more than 160 SKUs, with products exported to over 40 countries and regions worldwide.With years of dedication to the potato products industry, SnowValley has achieved an all-round internationalization upgrade spanning product exports, brand development, and industry-standard promotion, driven by quality and innovation as the core and supported by global operations.Looking ahead, SnowValley will continue to enhance its product R&D capabilities and expand its international presence. By delivering high-quality deep-processed potato products, SnowValley aims to empower the development of the global foodservice industry, promote the standardization and upgrading of the sector through leading quality, and continuously explore and create sustainable value within the global food supply chain.Company: SnowValley Food Hebei Co.,Ltd.Contact Person: Joyce YangEmail: sales@snowvalleyfood.comWebsite: https://snowvalleyfood.com/en/Telephone: +86 131 6429 9552City: Zhangjiakou, Hebei Province Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Using Personal Loans Wisely to Improve Your Money Situation in Singapore ACN Newswire

Using Personal Loans Wisely to Improve Your Money Situation in Singapore

SINGAPORE, June 4, 2026 - (ACN Newswire via SeaPRwire.com) - Managing money in a high-cost city like Singapore can feel complex, especially when multiple financial commitments run in parallel. From education expenses and medical bills to consolidating existing dues, Personal Loans in Singapore are often explored as a flexible financing option. When approached thoughtfully, they can help create breathing room in monthly cash flow and bring more structure to scattered payments. The key lies in understanding how these loans work in the local context and using them in ways that align with income patterns, interest rates, and realistic repayment timelines.Understanding how Personal Loans work in SingaporePersonal Loans in Singapore are unsecured loans, meaning they do not require collateral such as property or fixed deposits. Loan amounts can vary widely depending on income eligibility and lender criteria, subject to applicable regulatory requirements. Interest rates are often quoted as flat rates or effective interest rates (EIR), with EIRs commonly ranging between 2.65% and 3.75% per annum for salaried individuals. Understanding the difference between flat rates and EIRs, as well as how rates vary across lenders, can help borrowers estimate the actual cost of borrowing more accurately. Repayment tenures usually span from one to five years, offering flexibility to match monthly obligations with income cycles.Situations where Personal Loans may help improve cash flowPersonal Loans may be useful in specific scenarios where timing and predictability matter more than long-term borrowing. For instance, consolidating multiple high-interest payments into one structured loan can simplify finances and make monthly outflows easier to track. A consolidated single personal loan instalment per month may feel more manageable than juggling three or four smaller payments with varying due dates. Similarly, planned expenses such as professional certifications or home repairs may benefit from fixed monthly repayments rather than ad-hoc withdrawals from savings. This approach can help maintain liquidity while spreading costs over time.Using Personal Loans for Debt ConsolidationDebt consolidation is one of the more common reasons borrowers explore personal loans in Singapore, especially when dealing with credit card balances. For illustration purpose, credit cards may carry interest rates exceeding 25% per annum, which may strain monthly budgets if balances revolve. A Personal Loan with a materially lower EIR may help reduce the interest burden while providing a clear repayment end date. Over a three-year tenure, consolidating SGD 20,000 in outstanding balances may translate into more predictable instalments and less uncertainty around interest accumulation, depending on the applicable terms. This structured approach may help improve financial clarity without relying on short-term credit cycles.Practical tips to use Personal Loans thoughtfullyAlign the loan amount with a clear purposeBorrowing with a defined goal can help keep loan usage focused and intentional. Whether the aim is consolidating debt or funding a necessary expense, having a specific number in mind can prevent over-borrowing. In Singapore, lenders may offer higher limits based on income, but choosing only what is required can help keep monthly instalments comfortable. This approach may also reduce total interest paid over the loan tenure.Compare EIR, not just headline offersAdvertised rates can sometimes appear attractive, but the EIR provides a clearer picture of the total cost. Processing fees, early repayment charges, and administrative costs can influence the final amount paid. For example, a loan with a 3% flat rate can translate to an EIR closer to 5.5% once fees are factored in. Comparing EIRs across lenders can help identify options that fit better within monthly budgets.Choose a tenure that balances flexibility and affordabilityLonger tenures reduce monthly instalment amounts, but they also increase total interest paid. Shorter tenures may feel heavier on cash flow but can close the loan faster. Borrowers earning between SGD 4,000 and SGD 6,000 per month often opt for a two- to three-year tenure, as it balances instalment size with interest impact. Selecting a tenure that aligns with income stability can help maintain consistency in repayments.Understanding income-based borrowing limitsIn Singapore, borrowing limits for personal loans are typically tied to annual income levels and overall credit assessment. Individuals earning less than SGD 20,000 annually are generally subject to more restrictive unsecured credit caps, while those earning above SGD 30,000 may be eligible for higher unsecured credit limits, subject to the banks' internal credit assessments and applicable regulatory requirements. These guidelines are designed to encourage responsible borrowing without overextending financial capacity. Staying within these limits can help ensure that loan repayments remain proportionate to income, leaving room for savings and everyday expenses. This balance can support longer-term financial resilience rather than short-term relief.Building a healthier money outlook with structured repaymentsOne often overlooked benefit of personal loans is the predictability they bring to monthly planning. Fixed instalments can make it easier to map expenses, set aside savings, and track progress over time. Seeing a loan balance reduce each month steadily may also encourage better financial habits. In Singapore's fast-paced environment, this structure may help individuals stay focused on broader money goals while managing immediate needs. Over time, this clarity may contribute to improved confidence in handling finances.Making Personal Loans work for your financial contextUsing personal loans thoughtfully in Singapore can be a practical way to bring order to complex financial situations. When loan amounts, interest rates, and tenures are aligned with income and clear objectives, they can help improve cash flow and reduce financial stress. Rather than acting as a quick fix, personal loans can serve as a structured tool that supports better financial management. With careful comparison and realistic planning, they may fit into a broader strategy aimed at stability and long-term financial well-being.Disclaimer: This content is published by iQuanti Singapore Pte Ltd, an external marketer engaged and compensated by UOB LtdContact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
GR Premiers GRMN Corolla JCN Newswire

GR Premiers GRMN Corolla

Toyota City, Japan, June 4, 2026 - (JCN Newswire via SeaPRwire.com) - GAZOO Racing (GR) held the world premiere today of the GRMN Corolla―the ultimate GR Corolla, engineered to deliver a confident, full-throttle experience on Germany's Nürburgring racetrack, the starting point for both GR, which is committed to building ever-better motorsports-bred cars, and Toyota Master Driver Morizo. The GRMN Corolla represents a comprehensive honing of the GR Corolla ignited by Morizo's strong desire to "bring back a Corolla that captivates our customers".The GRMN Corolla is to be available in limited quantities, primarily in Japan, North America, and Australia. In Japan, plans are to accept sales negotiations requests via the "GR app" smartphone app from around autumn 2026, with sales scheduled to begin in 2027. The new model is now on display at the Fuji Motorsports Forest Welcome Center until June 28.*1GRMN Corolla (prototype in Black Gravite)The GRMN Corolla, as the ultimate GR Corolla, enables a high level of car-driver unity even when pushing the limits.Its increased engine torque aims to unleash greater untamed energy.It features exclusively designed aerodynamic performance parts and a suspension honed through competing in the Super Taikyu Series and testing at the Nürburgring.Its 4WD control was optimized through repeated testing at the Nürburgring.The cockpit is equipped with a custom-designed driver's seat and a brush-metal instrument panel and has been evolved for enabling the driver to focus more fully on driving.In addition to the 2-seater GRMN Corolla, a 5-seater MORIZO RR version equipped with the GAZOO Racing Direct Automatic Transmission is currently being developed.Aiming for a car that can attack the Nürburgring at full throttleSpurred by the stance of Toyota Motor Corporation Chairman and Master Driver Akio Toyoda, a.k.a. Morizo, of: "If it's going to bear the GRMN name, it needs to be a car that can duly handle the Nürburgring", the development team honed the GRMN Corolla on what is said to be the world's most grueling race course. Going all out on the Nürburgring, which provides road inputs and surface variations not found on regular test courses, highlights a car's weaknesses. Developing the GRMN Corolla at the Nürburgring enabled crafting a car that can be controlled at will at all speeds, even on rough surfaces.In addition to development through track testing at the Nürburgring, the GRMN Corolla also went through its paces in Japan's Super Taikyu Series. It was also methodically validated using advanced driving simulators. But it was driving it at the Nürburgring that brought unexpected challenges to the fore. The development team overcame those challenges one by one in pursuit of achieving a high level of car-driver unity, enabling the car and driver to remain in constant, effective communication even when pushing the limits.GR has applied the insights gained from GRMN Corolla development to the evolution of the base GR Corolla. For the 2026 GR Corolla, announced in September 2025 and launched in November of that year, the application of structural adhesive was extended by 13.9 meters to 32.7 meters to reinforce the body structure, and an added cool-air duct reduces the rise in intake air temperature during high-load driving. Both were the result of applying lessons learned at the Nürburgring.GRMN Corolla main featuresAerodynamic performance: Super Taikyu Series-tested and Nürburgring-honedIn Super Taikyu Series and similar races and at the Nürburgring, cars constantly travel at high speeds and experience high g-forces. Maximizing vehicle performance under these conditions crucially requires that all four wheels maintain firm contact with the road. The GRMN Corolla features exclusively developed aerodynamic performance parts for enhanced road holding. Its hood duct, fender ducts, front side spoilers, and rear wing incorporate know-how gained from racing, tested on the hydrogen engine-powered GR Corolla that competes in the Super Taikyu Series. Based on all-inclusive Super Taikyu Series trial and error, fine-tuning came at the Nürburgring. This effort included adjusting the rear wing angle, which features a five-step adjustment mechanism, in 1-degree increments during driving tests with professional drivers to verify effectiveness and determine the optimal specification.Exclusive suspension fine-tuned through extensive Nürburgring testingThe GRMN Corolla's suspension employs exclusive front and rear monotube shock absorbers with rebound springs for improved inner-wheel traction during cornering and for enhanced high-speed cornering performance.The Nürburgring road surface includes environments that induce significant vertical suspension travel beyond that experienced on typical circuits. To ensure high stability for confident driving even in such conditions, extensive Nürburgring test runs facilitated optimization of bump-stop characteristics. The exclusive shock absorbers were developed by adjusting their stroke down to a millimeter at the front and rear for optimal balance. Furthermore, for enhanced cornering stability and braking performance, the GRMN Corolla sports 245/40ZR18 "Michelin Pilot Sport Cup 2" high-grip tires, which are 10 mm wider than those on the base vehicle.The control program of the GRMN Corolla's EPS (electric power steering) has been modified from that on the base vehicle to generate the required amount of assistance torque even during cornering under high g-forces. The exclusively tuned 4WD control system provides optimal rear torque distribution during straight-line driving and enhanced stability at the onset of steering input at extremely high speeds.Internal combustion engine evolution via the hydrogen engine-powered CorollaGR has been gaining valuable lessons for the evolution of the internal combustion engine by competing in the Super Taikyu Series with a hydrogen engine-powered GR Corolla, as extended, high-load endurance racing helps heighten not only the potential of hydrogen technology but also that of fundamental internal combustion engine components. Applying insights gained from competing in the Super Taikyu Series has enabled the GRMN Corolla to achieve a maximum engine torque of 415 Nm*2, 15 Nm greater than that of the base vehicle. The development team optimized the GRMN Corolla's engine characteristics by analyzing the range of engine use during circuit driving, focusing on increasing torque in the 3,600-4,800 rpm mid-speed range, which is crucial for accelerating out of corners. To maintain stable, high engine output even during continuous full-throttle driving, the GRMN Corolla comes with an intercooler spray system, in addition to the cool-air duct added to the 2026 GR Corolla.Also, in pursuit of an even higher level of performance and an "untamed energy that captivates customers", the GRMN Corolla has no rear seats as part of an effort to achieve thorough weight reduction. The power-to-weight ratio has been improved by reducing weight by 30 kilograms compared to the base vehicle*3, providing customers with an unparalleled driving experience.A cockpit designed to unlock an even higher level of performanceThe GRMN Corolla boasts not only exclusively tuned driving performance but also a specially designed cockpit featuring a driver's seat and an instrument panel meticulously crafted to enable customers to unlock the value of genuine driving performance. The custom-designed full bucket driver's seat*4 was based on the driving position in Super Taikyu Series race cars to achieve holding performance capable of withstanding higher lateral g-forces. The carefully adjusted seat length facilitates clutch operation, and the seat's glass fiber-reinforced polymer (GFRP) construction helps reduce weight. In addition to safety being first and foremost, the aim was to create a driver's seat that enhances car-driver unity while considering everyday ease of ingress and egress. Development involved installing the seat in a car competing in the Super Taikyu Series and incorporating feedback from various professional drivers, including that from evaluations conducted while wearing a helmet.The cockpit's design and meticulously considered color scheme create a space that enables the driver to focus more fully on driving and features an exclusive flocked instrument panel and flocked front pillars. Carbon-fiber ornamentation―developed and manufactured by the Carbon Section at Toyota Motor Corporation's Motomachi Plant―adorns the instrument panel on the passenger side. Other special items include instrument panel padding bearing Morizo's signature, door trim and shift knob accented in Alumite Red, and a GRMN-exclusive serial number plate. GR Corolla MORIZO RR (concept model)Currently under development is the GR Corolla MORIZO RR, an ultimate 5-seater model of the GR Corolla equipped with the GAZOO Racing Direct Automatic Transmission, for which the unveiling and launch dates have yet to be determined. The GR Corolla MORIZO RR is now on display as a concept model alongside the GRMN Corolla at the Fuji Motorsports Forest Welcome Center until June 28.*1*1 Please check the Fuji Motorsports Forest website (https://en.fujimotorsportsforest.jp/) for information on closed days and public opening hours during the exhibition period.*2 415 Nm is the maximum engine torque for the Japan-specification model*3 Maximum engine torque and vehicle weight vary by market.*4 Only in Japan and Australia; semi-bucket seats in North AmericaToyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.SDGs Initiatives: https://global.toyota/en/sustainability/sdgs/ Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
云顶新耀与天广实达成倍捷欣(R)商业化授权许可协议 深化亚太创新药市场布局 ACN Newswire

云顶新耀与天广实达成倍捷欣(R)商业化授权许可协议 深化亚太创新药市场布局

香港, 2026年6月4日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀(HKEX 1952.HK)宣布与北京天广实生物技术股份有限公司(以下简称"天广实")达成商业化授权许可合作协议,获得倍捷欣(R)(MIL62,通用名:奥妥珠单抗β注射液)在亚太地区(东南亚、印度、韩国、澳大利亚、新西兰、中国香港、中国澳门及中国台湾地区)的临床开发及商业化权益。根据相关协议,云顶新耀将向天广实支付人民币2,300万元的首付款,以及最高不超过人民币1.86亿元的销售里程碑款。天广实可获得该产品在亚太地区的销售毛利额分成款项。此次合作将进一步强化云顶新耀在肾科及自身免疫疾病等领域的亚太市场布局,并与现有肾科管线形成协同效应。云顶新耀将依托已获验证的临床开发及商业化能力,加速推动倍捷欣(R)的市场准入与商业化进程,持续释放亚太区域的增长潜力,并推进公司在全球创新药市场的长期战略发展。倍捷欣(R)是天广实自主研发的创新型第三代CD20抗体药物。根据相关资料显示,该药物已于2026年2月在中国获批上市,用于治疗视神经脊髓炎谱系疾病(NMOSD),成为全球首款治疗该疾病的CD20抗体,也是中国在该领域的首款国产药物。倍捷欣(R)用于治疗原发性膜性肾病(PMN)的新药上市申请亦处于中国国家药监局的"优先审评审批"阶段,有望成为全球首款获批的PMN特效药物。此外,倍捷欣(R)正在进行的临床III期试验覆盖系统性红斑狼疮(SLE)以及滤泡性淋巴瘤(FL)多个治疗领域,并具备向其他自身免疫性疾病持续拓展的潜力。云顶新耀董事会主席吴以芳表示:"我们非常高兴能与天广实就倍捷欣(R)达成此次合作。倍捷欣(R)不仅是全球首款获批治疗NMOSD的CD20抗体,也是一款具有差异化优势和广阔市场前景的创新药,在肾科及自身免疫疾病领域展现出显著的临床潜力。此次合作将进一步丰富云顶新耀在肾科及自身免疫领域的产品布局,并与现有管线形成良好的协同效应。依托公司已建立并持续强化的临床开发及商业化能力,我们有信心加速推进倍捷欣(R)在亚太地区的开发与商业化进程,推动其尽快惠及更多患者,让创新疗法更快转化为临床可及性,并进一步提升公司在亚太及全球创新药市场的影响力。"天广实总裁陈鲁宁表示:"我们非常欣喜与云顶新耀达成倍捷欣(R)在亚太地区的合作。倍捷欣(R)作为全球首款获批治疗NMOSD的CD20靶向药物,也是潜在全球首款治疗PMN的特效药物,拥有非常出色的产品竞争力与市场潜力。自产品上市以来,倍捷欣(R)在中国大陆地区已经取得了优异的商业化成绩,此次合作将进一步强化倍捷欣(R)在整个亚太市场的商业化网络与品牌影响力,为中国大陆以外的更多肾科及自身免疫性疾病患者带来「欣」希望。"倍捷欣(R)目前已在肾科及多个自身免疫疾病领域展现出显著的临床及治疗价值,并具备广阔的适应症拓展潜力。其在NMOSD、PMN及SLE等疾病领域的持续布局与进展,有望为患者带来更多创新治疗选择。NMOSD是一种高复发率、高致残率的中枢神经系统自身免疫性疾病,多发于青壮年女性。该病通常为急性或亚急性起病,可迅速进展,约90%的患者在三年内经历复发,严重者可导致失明甚至瘫痪。倍捷欣(R)在单药治疗中显示出降低复发风险的显著优势,并在疗效数据中展现出优异表现,凸显其作为单药疗法的临床价值与治疗便利性。PMN是成人肾病最常见的病理类型,约30%-40% 的患者在5-15年内可能进展为终末期肾病。目前全球范围内尚无获批的特效药。临床III期研究显示,倍捷欣(R)单药治疗在临床完全缓解、免疫学完全缓解及临床缓解等各项指标上均展现出显著优势。此外,倍捷欣(R)具有良好的安全性和耐受性,并且给药周期便捷,患者初始治疗后,每六个月仅需进行一次静脉注射,可显著降低治疗负担,同时有助于提升长期依从性。SLE是一种慢性系统性自身免疫疾病,倍捷欣(R)目前处于临床III期研究阶段,具有24–28周的长给药间隔优势,可满足患者对长效治疗方案的临床需求,有望为SLE患者提供更优治疗选择。此次合作被视为云顶新耀提升肾科及自身免疫领域战略纵深的重要举措。随着倍捷欣(R)在PMN等适应症上的开发与商业化推进,公司肾科产品矩阵将得到进一步补充,并强化现有管线的协同效应。此外,业内普遍认为,未来数年中国创新药加速进入亚太市场将迎来重要发展机遇。凭借临床价值、可负担性及可及性方面的综合优势,中国创新药与亚太地区日益增长的医疗需求持续契合。云顶新耀近年来持续推进亚太区域战略布局,已逐步形成覆盖临床开发、市场准入及商业化运营的能力体系。通过引入倍捷欣(R)等具备差异化临床价值的创新产品,云顶新耀正进一步拓展区域产品组合及市场覆盖,推动公司肾科及自身免疫领域商业化价值的释放,并为亚太业务发展注入新的增长动能。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market ACN Newswire

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

HONG KONG, Jun 4, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. (“Mabworks”), under which the Company has obtained exclusive rights for the clinical development and commercialization of Bejescin(R) (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast Asia, India, South Korea, Australia, New Zealand, Hong Kong SAR, Macao SAR, and Taiwan region, China. Under the terms of the agreement, Everest Medicines will pay Mabworks an upfront payment of RMB 23 million and sales milestone payments of up to RMB 186 million. Mabworks will also be eligible to receive a share of gross profit in the region.This collaboration will strengthen Everest Medicines’ presence in nephrology and autoimmune diseases across the Asia-Pacific region, creating synergies with its nephrology portfolio. Leveraging its established and proven clinical development and commercialization capabilities, the company aims to advance the development of Bejescin(R) and support its launch in the Asia-Pacific region, while furthering its long-term strategy in the global innovative medicines market.Bejescin(R) (MIL62, Obinutuzumab beta Injection) is a novel third-generation anti-CD20 monoclonal antibody. As shown in relevant sources, it was approved in China in February 2026 for the treatment of neuromyelitis optica spectrum disorder (NMOSD), becoming the first CD20 antibody approved for this indication globally and the first domestically developed therapy in China. The New Drug Application (NDA) for primary membranous nephropathy (PMN) is currently under Priority Review by the National Medical Products Administration (NMPA), with the potential to become the first approved targeted therapy for PMN worldwide. Bejescin(R) is also in Phase III trials for systemic lupus erythematosus (SLE) and follicular lymphoma (FL), with potential for further expansion into other autoimmune indications.“We are delighted to collaborate with Mabworks on Bejescin(R). As the first CD20 antibody approved globally for NMOSD, Bejescin(R) has demonstrated strong clinical potential and significant opportunities in nephrology and autoimmune diseases,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “This collaboration strengthens Everest’s portfolio in these therapeutic areas and complements our existing pipeline. With our expertise in clinical development and commercialization, we are confident in advancing Bejescin(R) across the Asia-Pacific region, bringing this innovative therapy to more patients and improving access. At the same time, we are committed to further strengthening Everest Medicines’ presence in the Asia-Pacific and global innovative medicines market.”“We are thrilled to announce our partnership with Everest Medicines on Bejescin(R) across the Asia-Pacific region. As the first approved CD20-targeted therapy for NMOSD worldwide and the potential global first targeted therapy for PMN, Bejescin(R) possesses exceptional product competitiveness and market potential.” said Mr. Luning Chen, President of Mabworks. “Since its launch in Mainland China, Bejescin(R) has achieved outstanding commercial performance. This collaboration will further strengthen Bejescin(R)’s commercial network and brand influence across the Asia-Pacific region, bringing ‘New Hope’ to more patients with renal and autoimmune diseases.”Bejescin(R) has shown meaningful clinical and therapeutic benefits across nephrology and multiple autoimmune disease areas, with potential for further indication expansion. Its development in NMOSD, PMN, and SLE is expected to provide more innovative treatment options for patients.NMOSD is a debilitating autoimmune disorder targeting the central nervous system characterized by high recurrence and disability rates, predominantly affecting young and middle-aged women. The disease typically presents acute or subacute onset and can progress rapidly, with approximately 90% of patients relapsing within three years. Severe cases may result in blindness or paralysis. Bejescin(R) has demonstrated a significant reduction in relapse risk as a monotherapy, with strong efficacy data underscoring both its clinical value and the convenience.PMN is one of the most common pathological types of adult nephropathy, with approximately 30%-40% of patients progressing to end-stage renal disease (ESRD) within 5 to 15 years. Globally, there are no approved targeted therapies for PMN. Phase III clinical data demonstrated that Bejescin(R) monotherapy provides significant advantages across multiple efficacy endpoints including complete clinical remission, complete immunological remission and overall clinical remission. Furthermore, Bejescin(R) showed a favorable safety and tolerability profile, together with a convenient dosing regimen. Following initial treatment, patients require only one intravenous infusion every six months, reducing treatment burden and supporting long-term treatment adherence.SLE is a chronic, systemic autoimmune disease that primarily affects young women. For this indication, Bejescin(R) is in Phase III clinical trial and offers the potential for administration every 24 to 28 weeks, addressing the need for long-acting therapies and providing an improved treatment option for patients with SLE.This collaboration is regarded as an important strategic step for Everest Medicines to deepen its footprint in the nephrology and autoimmune disease areas. With the development and commercialization of Bejescin(R) in indications such as PMN, the company’s nephrology product portfolio will be further strengthened, enhancing the synergistic effects within its existing pipeline.In addition, there is a broad consensus in the industry that the coming years may represent an important window of opportunity for the accelerated adoption of innovative Chinese medicines into the Asia Pacific region. Chinese innovation is becoming increasingly competitive in clinical value, affordability and accessibility, with growing alignment to the needs of healthcare systems and patients across the region. In recent years, Everest Medicines has continuously advanced its regional strategy in Asia-Pacific, gradually building an integrated capability system covering clinical development, market access, and commercialization. By introducing innovative products with differentiated clinical value such as Bejescin(R), the company is further expanding its regional product portfolio and market coverage, realizing the commercial value of its nephrology and autoimmune disease businesses, and injecting new growth momentum into its Asia-Pacific operations. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

加速兑现股东回报,赤子城科技注销逾517万股回购股份

EQS via SeaPRwire.com / 2026-06-04 / 19:30 UTC+8 6月4日,赤子城科技发布公告称,公司已注销此前于2026年4月27日至5月29日期间购回的合共517.4万股股份,涉及总回购金额约4532万港元。 此前,赤子城科技于2026年3月宣布,计划未来两年斥资约3亿港元在市场上进行股份回购。公告显示,本次注销后,赤子城科技已发行股份总数将由14.13208391亿股减少至14.08034391亿股,公司不再持有任何库存股份。 赤子城科技董事会表示,注销购回股份将提高每股股份资产净值及每股股份盈利,符合公司及股东整体利益,董事会将继续不时检讨及全权酌情决定进行股份购回。公司近期已连续推进回购及注销动作,向市场释放出管理层对公司长期发展前景的信心,也体现出其对股东回报和资本效率的重视。 自今年3月纳入港股通以来,赤子城科技累计成交额大幅提升,南向资金参与热情持续升温。从回购时点看,此轮回购正值公司一季报发布后。4月22日,赤子城科技披露2026 年第一季度未经审核营运数据,期内总收入预期约20.30 亿~21.30亿元人民币,同比增长约33.0%~39.6%。其中,核心社交业务同比增长约31.3%~37.2%;创新业务同比增长约46.7%~58.7%,主要得益于AI驱动下短剧业务的快速增长。 2026-06-04 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
More

SeaPRwire 打通印泰越主流媒体生态

Hong Kong - 2026年6月3日 - (SeaPRwire) - 东南亚正在成为全球经济增长的新引擎,而印尼、泰国和越南则是其中最耀眼的“活力三驾马车”。为了助力全球企业抢占东南亚市场红利,知名媒体服务商 SeaPRwire 今日宣布,已成功深度打通印度尼西亚、泰国和越南三国的本地主流媒体生态,为出海企业构建了直达东南亚亿级消费者的公关绿色通道。 印尼的人口红利、泰国的消费活力以及越南的制造与科技崛起,让这三个国家成为各行各业出海的必争之地。然而,东南亚地区语言多样、媒体形态分散,且各国的宗教文化背景迥异,这给外来品牌的公关传播带来了极大的挑战。SeaPRwire 此次深入本土的拓展,正是为了解决这一痛点。 在印尼,SeaPRwire 强化了与雅加达主流印尼语门户及高流量社交媒体矩阵的合作;在泰国,平台无缝对接了曼谷核心的泰语财经与时尚生活类媒体;在越南,则重点布局了河内与胡志明市的科技、创投以及年轻一代高度依赖的数字媒体。通过这种精细化的本土媒体下沉,SeaPRwire 确保企业的信息能够准确、无损地传达给当地最具消费力的群体。 “开拓东南亚市场,‘接地气’是第一要素,”SeaPRwire 的东南亚市场总监表示,“我们不仅仅是把英文稿件翻译成当地语言,更是深入到印泰越三国的媒体生态毛细血管中。我们希望用最符合当地语境的新闻叙事,帮助企业建立起有温度、有信任度的本土品牌形象。” 关于SeaPRwire SeaPRwire 是亚洲领先的 AI 驱动型赢取媒体(Earned Media)传播管理平台,专为公关及传播专业人士打造。通过其旗舰项目 Branding-Insight,平台无缝连接超过 8 万名记者、编辑,以及坐拥 3 亿粉丝的 KOL 矩阵。借助先进的 AI 技术,SeaPRwire 帮助用户精准锁定媒体目标、定制个性化推介,并全面衡量亚太核心市场(包括日、韩、中及东南亚)的公关传播效果。 媒体联络 公司: SeaPRwire 联络: Media team 邮箱: cs@seaprwire.com 网站: https://seaprwire.com
More

Hymson Highlights Operational Reliability at The Battery Show Europe 2026

EQS Newswire / 03/06/2026 / 11:12 UTC+8 From Cell to System. From proven manufacturing experience to localized European support. Not only broad technology coverage, but the operational stability you can depend on. June 9–11, 2026 | Booth 1-B30 European battery manufacturers are moving beyond equipment procurement toward industrial ramp-up, where yield, uptime, process discipline, and local service capability determine long-term competitiveness. As battery manufacturing moves from pilot validation toward industrial-scale production, operational reliability is becoming increasingly critical across the industry. At The Battery Show Europe 2026, Hymson returns for its fifth consecutive year with a clear message for the European market: “How we make it reliable.” From process validation to mass production. Battery industrialization is not only about installing equipment. It requires process validation, operator training, spare parts readiness, data visibility, and continuous improvement mechanisms. Over the past five years, Hymson has continued to deepen its engagement with the European market, working alongside battery manufacturers amid evolving production demands, technology transitions, and industrial-scaling challenges. This long-term collaboration has enabled Hymson to continuously refine both its technologies and manufacturing methodologies for global battery production environments. Behind this commitment is sustained investment in innovation and engineering capability. By 2025, Hymson’s cumulative R&D investment will reach USD 86 million, with 34.47% of employees dedicated to R&D. Total operating revenue is projected to reach USD 939 million in 2026, supporting continued advancement in next-generation battery manufacturing technologies and industrial delivery capability. Mid-Section Turnkey Solutions for Scalable Manufacturing At Booth 1-B30, Hymson will present its latest Mid-Section Turnkey Solution through a comprehensive product matrix and a series of scaled technology models showcasing key manufacturing innovations, alongside extensive battery process samples demonstrating end-to-end manufacturing capabilities. The scaled equipment models on display include: Solid-State Dry-Electrode Solution Film-Forming & Calendering & Lamination Integrated Machine 390 High-Speed Cutting & Stacking Machine CT Inspection Machine for Prismatic Assembly Through these scaled technology models, Hymson will provide visitors with a more intuitive understanding of process integration, equipment architecture, and manufacturing workflow within next-generation battery production environments. Hymson will also showcase: 588Ah Cell Samples Developed for Overseas Customer Requirements 588Ah Cell Cap & Can Laser Welding Samples 40+ process samples covering electrode manufacturing, surface treatment, prismatic assembly, and stacking technologies Together, these exhibits reflect Hymson’s integrated approach to mid-section manufacturing — combining process capability, operational consistency, and scalable production performance. Reliability Starts from Cell Design For Hymson, manufacturing reliability does not begin at equipment installation or even at mass production. It begins much earlier — at the cell design and manufacturability assessment stage. To support customers throughout the entire industrialization journey, Hymson provides an integrated consulting and engineering support framework covering: Cell Design to Manufacturing Production Line Planning Mass Production Line Ramp-up Support Training A key focus within this framework is manufacturability validation before mass production. For many next-generation battery technologies, laboratory-level performance alone is not sufficient for successful industrialization. To reduce scaling risks, Hymson provides DOE (Design of Experiments) and DTM-based battery process analysis to support parameter optimization, blueprint evaluation, and manufacturability feasibility study. Through this process, Hymson helps customers establish: Optimized Process Parameters Manufacturable Battery Analysis Stable Transition from Validation to Mass Production Reduced Ramp-Up Uncertainty and Operational Risks Hymson helps customers translate validated pilot-line conditions into scalable mass-production workflows with thousands of successful delivery and implementation experiences as lessons learned, transitioning into Know-How for the customers, enabling smoother and more accurate alignment between pilot validation and large-scale production environments. This approach helps minimize the risks of industrialization while accelerating mass-production readiness. Technical discussions and in-depth solution exchanges will be available throughout the exhibition. Digitalized Operations for Long-Term Stability Beyond manufacturing equipment, Hymson will also present its End-to-End intelligent manufacturing support across equipment, logistics, and operations management This includes Hymson’s intelligent warehousing & logistics solution together with the IEMS intelligent equipment operation and maintenance system. Driven by AI algorithms and 3D visual monitoring technologies, the system enables: Digital Closed-Loop Production Real-Time Operational Visibility Intelligent Equipment Maintenance Data-Driven Production Management Dark-Factory-Oriented Operation Scenarios The system supports higher levels of automation and unmanned operation where applicable by integrating manufacturing execution, logistics coordination, and equipment operation into a unified system, Hymson helps customers improve operational transparency, production efficiency, and long-term factory stability. Spare Parts Support Built Around Operational Continuity To further strengthen production reliability, Hymson continues to enhance its global spare parts service capability. Hymson provides both original Hymson spare parts and third-party qualified industrial spare parts, tailored to customer requirements, supported by flexible supply mechanisms and predictive inventory planning. The service framework helps customers secure: Critical Spare Parts Availability Improved Price and Lead-Time Predictability Reduced Downtime Risks Lower Inventory Burden Where Applicable Optimized Total Cost of Ownership (TCO) Through data-driven spare parts forecasting and scheduled replenishment systems, Hymson aims to establish a replicable, stable after-sales support structure for long-term manufacturing operations. Advancing Reliable Battery Manufacturing from Asia to Europe Returning to The Battery Show Europe 2026 for the fifth consecutive year reflects Hymson’s long-term commitment to supporting Europe’s battery manufacturing ecosystem. From process development to intelligent factory operations, Hymson continues to combine large-scale manufacturing experience from Asia with localized industrial collaboration in Europe — helping battery manufacturers build production systems designed not only for technological advancement but also for reliable long-term operation. As Hymson has always stated, visitors are invited to discuss specific challenges such as process validation, ramp-up risk reduction, equipment OEE improvement, spare parts planning, and localized service support. Company: Hymson Laser Technology Group Co., Ltd. Contact Person: liruiyu Email: liruiyu@hymson.com Website: https://www.hymson.com 03/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News
More
4共和党人反水!特朗普对伊战争权力遭国会钳制,党内裂痕彻底炸锅 Latest News

4共和党人反水!特朗普对伊战争权力遭国会钳制,党内裂痕彻底炸锅

(SeaPRwire) -By: Alistair Kroon, a well-known overseas geopolitical commentator who frequently publishes editorials in mainstream newspapers 2026年5月30日,华盛顿特区日落时分的美国国会大厦。——Kevin Carter—Getty Images 特朗普的对伊战争权力,终于被国会的自己人摁住了。四名共和党众议员公然跨党站队民主党,通过了限制他军事行动的决议。这场投票撕开的,是共和党内部对特朗普中东政策的不满裂痕,而且这裂痕只会越来越大。 官方说辞里,这场投票是国会履行宪法制衡的责任。众议院外交委员会民主党籍资深成员Gregory Meeks提出决议,要求特朗普终止对伊敌对行动。投票结果215票赞成、208票反对,四名共和党人——Thomas Massie、Brian Fitzpatrick、Tom Barrett、Warren Davidson——倒戈支持。原本5月21日就要投票,共和党领导层见局势不妙,紧急休会推迟。但背后的真实动因,是共和党选民的怒火。肯塔基州的农民买不起化肥,全国民众面对每加仑5美元的汽油、6美元的柴油,早已忍无可忍。Massie就是因为多次批评特朗普未经授权动武,刚在党内初选中输给了特朗普背书的Ed Gallrein。 特朗普政府辩称,4月8日的停火协议已终结战争,无需国会批准。国防部长Pete Hegseth还称,1973年战争权力法案规定的60天授权时钟已重置。众议院议长Mike Johnson则称,这场投票会削弱特朗普与伊朗谈判的筹码。但现实是,停火只是自欺欺人。特朗普自己都承认,中东的停火就是“适度射击”。就在投票前一天,美军袭击伊朗格什姆岛,伊朗随即报复科威特机场和巴林美军基地。与此同时,五角大楼、国务院和美国国际开发署的监察长宣布联合审查这场战争,称法律要求对超过60天的海外军事行动展开调查。Fitzpatrick直言,要么遵守法律提交国会批准,要么修改法律,没有违法的选项。共和党内部的反抗不止于此:参议院共和党人刚逼特朗普取消了18亿美元的“反武器化基金”,又砍掉了他宴会厅安保的拨款。 这场投票撕开的裂痕,再也无法弥合。特朗普的对伊政策将失去党内支持,中东的军事对峙只会持续升级,美国的地缘影响力正在加速衰退。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

SeaPRwire 打通印泰越主流媒体生态

EQS via SeaPRwire.com / 2026-06-04 / 11:06 UTC+8 Hong Kong - 2026年6月3日 - (SeaPRwire) - 东南亚正在成为全球经济增长的新引擎,而印尼、泰国和越南则是其中最耀眼的“活力三驾马车”。为了助力全球企业抢占东南亚市场红利,知名媒体服务商 SeaPRwire 今日宣布,已成功深度打通印度尼西亚、泰国和越南三国的本地主流媒体生态,为出海企业构建了直达东南亚亿级消费者的公关绿色通道。 印尼的人口红利、泰国的消费活力以及越南的制造与科技崛起,让这三个国家成为各行各业出海的必争之地。然而,东南亚地区语言多样、媒体形态分散,且各国的宗教文化背景迥异,这给外来品牌的公关传播带来了极大的挑战。SeaPRwire 此次深入本土的拓展,正是为了解决这一痛点。 在印尼,SeaPRwire 强化了与雅加达主流印尼语门户及高流量社交媒体矩阵的合作;在泰国,平台无缝对接了曼谷核心的泰语财经与时尚生活类媒体;在越南,则重点布局了河内与胡志明市的科技、创投以及年轻一代高度依赖的数字媒体。通过这种精细化的本土媒体下沉,SeaPRwire 确保企业的信息能够准确、无损地传达给当地最具消费力的群体。 “开拓东南亚市场,‘接地气’是第一要素,”SeaPRwire 的东南亚市场总监表示,“我们不仅仅是把英文稿件翻译成当地语言,更是深入到印泰越三国的媒体生态毛细血管中。我们希望用最符合当地语境的新闻叙事,帮助企业建立起有温度、有信任度的本土品牌形象。” 关于SeaPRwire SeaPRwire 是亚洲领先的 AI 驱动型赢取媒体(Earned Media)传播管理平台,专为公关及传播专业人士打造。通过其旗舰项目 Branding-Insight,平台无缝连接超过 8 万名记者、编辑,以及坐拥 3 亿粉丝的 KOL 矩阵。借助先进的 AI 技术,SeaPRwire 帮助用户精准锁定媒体目标、定制个性化推介,并全面衡量亚太核心市场(包括日、韩、中及东南亚)的公关传播效果。 媒体联络 公司: SeaPRwire 联络: Media team 邮箱: cs@seaprwire.com 网站: https://seaprwire.com 2026-06-04 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
More
Island States Ocean Summit Opens in Tokyo JCN Newswire

Island States Ocean Summit Opens in Tokyo

TOKYO, June 4, 2026 - (JCN Newswire via SeaPRwire.com) - The Nippon Foundation, in partnership with the Ministry of Foreign Affairs of Japan and the Intergovernmental Oceanographic Commission (IOC) of UNESCO, officially opened the Island States Ocean Summit on June 3, 2026 at Hotel New Otani Tokyo. His Majesty the Emperor attended the Opening Ceremony and delivered remarks. Prime Minister Sanae Takaichi also attended the Opening Ceremony and delivered an address, underscoring the Government of Japan’s strong support for the Summit and its outcomes. Approximately 300 participants, including heads of state, ministers, senior officials, and experts from 35 countries across the Pacific, Caribbean, and Indian Ocean regions, are taking part in the Summit.Building on discussions held throughout the two-day Summit, The Nippon Foundation will announce a new action plan to strengthen support for island states on the evening of June 4.Remarks by His Majesty the EmperorAt the Opening Ceremony, His Majesty the Emperor delivered remarks. The full text of His Majesty’s remarks is attached as Annex 1.Opening Ceremony HighlightsRepresenting the host organization, Yohei Sasakawa, Honorary Chair of The Nippon Foundation, delivered the opening address.Mr. Sasakawa stated:“Today, island states face serious threats, including sea-level rise and extreme weather events caused by climate change. These challenges can no longer be solved by any one country or institution alone. Through this Summit, we must bring together our wisdom and determination to inspire global solidarity and action.”He reaffirmed the Foundation’s commitment to further strengthening its support for island states through the outcomes of the Summit.His Royal Highness Crown Prince Haakon of Norway emphasized the importance of Sustainable Ocean Planning and Management, stating:“At the same time, the ocean is not only a victim of climate change. It is a solution, continuing to offer opportunities that can bring benefits to nature and people in island states. Sustainable ocean planning and management can create frameworks for attracting investment in green ocean industries.”He highlighted the importance of strengthening climate resilience in island states while advancing sustainable ocean economies through science-based ocean management.Speaking on behalf of island states and serving as Summit Co-Chair, H.E. Surangel S. Whipps Jr., President of the Republic of Palau and Chair of the Alliance of Small Island States (AOSIS), stated:“The ocean is not a backdrop to our lives. It is our economy. Our food security. Our culture. Our very sovereignty. And it is changing faster than our communities can adapt. As AOSIS Chair, I speak for nations that together contribute less than one percent of global emissions, yet we face the most severe impacts of global warming. International climate and ocean governance is not delivering for the most vulnerable. We need action that matches the urgency.”Keynote Addresses and Group PhotoFollowing the Opening Ceremony, keynote addresses were delivered in the presence of His Majesty the Emperor and Crown Prince Haakon of Norway.H.E. Mr Peter Thomson, United Nations Secretary-General’s Special Envoy for the Ocean, and Mr. Vidar Helgesen, Executive Secretary of the Intergovernmental Oceanographic Commission (IOC) of UNESCO, stressed that there can be no healthy planet without a healthy ocean and highlighted the importance of island states advancing Sustainable Ocean Planning and Management (SOPM).The Summit will continue on June 4, focusing on practical measures and support mechanisms that enable island states to achieve both conservation and sustainable use of their ocean resources.A Co-Chairs’ Summary will be released on the evening of June 4. Building on that Summary, the Nippon Foundation will announce a new ten-year action plan to strengthen support for island states.About the Island States Ocean SummitIsland States, especially Small Island Developing States (SIDS), are widely recognized as being among the states most affected by the impacts of climate change and face an urgent need to strengthen their resilience in response to unprecedented environmental changes.The Island States Ocean Summit is the first international summit dedicated specifically to oceans and island states and aims to explore pathways that support the long-term resilience and self-reliance of SIDS. In collaboration with leaders from government, academia, industry, and the ocean community, the Summit promotes the development of new action plans that support the conservation of marine environments while enabling the sustainable use of ocean resources.The Summit discussions are co-chaired by H.E. Surangel S. Whipps Jr., President of the Republic of Palau and Chair of the Alliance of Small Island States (AOSIS), Mr. Vidar Helgesen, Executive Secretary of the Intergovernmental Oceanographic Commission (IOC) of UNESCO, and Mr. Yohei Sasakawa, Honorary Chair of The Nippon Foundation.The outcomes of the Summit will contribute to future international discussions on biodiversity, climate change, and ocean governance, including COP17 of the Convention on Biological Diversity (CBD), COP31 of the United Nations Framework Convention on Climate Change (UNFCCC), the BBNJ process, and the 2027 Ocean Decade Conference through the Intergovernmental Oceanographic Commission (IOC) of UNESCO.About Sustainable Ocean Planning and Management (SOPM)Sustainable Ocean Planning and Management (SOPM) is a comprehensive, strategic and future-oriented framework designed to guide decision-making about the overall sustainable use and conservation of a nation’s entire ocean resources. It is a whole-of-society, whole-of-government approach that serves as a unifying umbrella framework for ocean-related governance at all scales.By developing integrated plans for fisheries, tourism, renewable energy, and other oceanbased industries, SOPM helps countries strengthen climate resilience while ensuring the longterm sustainability of marine ecosystems and coastal communities.The Island States Ocean Summit supports island states in accelerating the adoption and implementation of SOPM and strengthening their capacity to balance ocean conservation, sustainable economic development, and climate resilience.About The Nippon Foundation https://www.nippon-foundation.or.jp/ Together, for pain and hope. Together, for the future. Established in 1962, The Nippon Foundation is Japan’s largest philanthropic foundation. The Foundation supports a broad range of initiatives including humanitarian assistance, disability inclusion, child welfare, disaster response, and ocean conservation.Media ContactIsland States Ocean Summit Press Desk (within Kyodo PR)Email: isos-pr@kyodo-pr.co.jp Annex 1: Remarks by His Majesty the EmperorYour Royal Highness Crown Prince Haakon of the Kingdom of Norway, Prime Minister Takaichi,Your Excellencies, Dr. Yohei Sasakawa, Distinguished Guests and Participants,It gives me great pleasure to be here today to attend the opening of the Island States Ocean Summit together with all of you. Japan, as an island nation, has from ancient times reaped the rich blessings of the ocean. As we witness rising sea levels due to global warming and a series of disasters caused by extreme weather around the world, I am deeply reminded of the importance of maintaining the delicate balance on Earth through the grand water cycle, where water is brought in from the sea and returns to the sea.I myself have for many years been interested in water issues, including safe drinking water, sanitation, water transport, climate change and water-related natural disasters, which are deeply intertwined with national and global challenges. I have always hoped that discussions on these issues would be deepened further around the world.It is my understanding that the purpose of this summit is to promote, through collaboration between private organizations, governments, and international organizations, national-level plans in island nations that aim to achieve both marine environment conservation and sustainable use of marine resources. I would like to express my sincere respect to all of you gathered here and to the participating nations, as you cooperate in sharing your collective wisdom and experience, and, by building upon the latest science while at the same time preserving traditions, endeavor to address global issues through international cooperation.To be mindful of the ocean and to work for its sound future is, in essence, nothing less than to safeguard our own future. As we face in our times many challenges, including rising sea levels, it is my earnest hope that a sense of solidarity among us will bring harmony and hope to the world. I extend my heartfelt gratitude to you all.Press Release: http://www.acnnewswire.com/docs/files/2026604.pdf Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More

SeaPRwire Taps Mainstream Media in Indonesia, Thailand, and Vietnam

Hong Kong – June 03, 2026 – (SeaPRwire) – Southeast Asia is becoming a new engine of global economic growth, with Indonesia, Thailand, and Vietnam acting as the most dazzling “vibrant troika” among them. To help global enterprises seize the dividends of the Southeast Asian market, renowned media service provider SeaPRwire (https://seaprwire.com) announced today that it has successfully and deeply tapped the local mainstream media ecosystems of Indonesia, Thailand, and Vietnam, building a PR green channel reaching hundreds of millions of consumers in Southeast Asia directly for overseas enterprises. Indonesia’s demographic dividend, Thailand’s consumer vitality, and Vietnam’s rise in manufacturing and technology have made these three countries must-contend spots for all industries going overseas. However, the Southeast Asian region features diverse languages, scattered media forms, and vastly different religious and cultural backgrounds across countries, posing enormous challenges to the PR communication of foreign brands. SeaPRwire’s localized expansion this time is precisely to solve this pain point. In Indonesia, SeaPRwire has strengthened cooperation with mainstream Indonesian-language portals in Jakarta and high-traffic social media matrices; in Thailand, the platform seamlessly interfaced with core Thai-language financial and fashion lifestyle media in Bangkok; and in Vietnam, it focused its layout on technology, venture capital, and digital media highly relied upon by the younger generation in Hanoi and Ho Chi Minh City. Through this refined localized media sinking, SeaPRwire ensures that enterprise information can be accurately and losslessly delivered to the most consumable local groups. “To explore the Southeast Asian market, ‘groundedness’ is the primary factor,” stated SeaPRwire’s Southeast Asia marketing director. “We are not just translating English drafts into local languages; we are penetrating deep into the media ecosystem capillaries of Indonesia, Thailand, and Vietnam. We hope to use news storytelling that best fits local contexts to help enterprises establish a warm and trusted local brand image.” About SeaPRwire SeaPRwire is Asia’s leading AI-driven earned media management platform, purpose-built to empower PR and communications professionals. Through its flagship Branding-Insight Program, the platform connects clients to over 80,000 journalists and an influencer matrix reaching 300 million followers. Leveraging advanced AI, SeaPRwire helps users identify media targets, personalize pitches, and measure PR impact across key APAC markets, including Japan, China, Korea, and Southeast Asia. Media Contact Company: SeaPRwire Contact: Media Relations Team Email: cs@seaprwire.com Website: https://seaprwire.com
More

SpeakUp裁掉所有员工让AI当老板?这事儿藏着数字企业的未来

(SeaPRwire) -张明宇是易观分析的资深数字平台分析师,他最近跟我聊起SpeakUp的操作时,语气里带着点兴奋又有点严肃:“现在很多公司喊AI赋能,其实就是用AI做些自动回复、数据统计的杂活。但SpeakUp不一样——他们直接把全团队换成了AI,31个专门的AI agent管着销售、用户入职、客服、内容创作这些原本需要好几个部门的活儿。这不是效率提升,是把公司的底层逻辑换了,从人驱动变成AI驱动。” 张明宇的话让我想起SpeakUp这个平台——它连接会议组织者、播客主、品牌方、媒体和演讲者,2025年公开上线,才一年时间用户就超过10万人,覆盖28个国家9种语言。他们的AI匹配引擎能根据主题专长、语言、预算、受众画像和地理位置自动推荐合适的演讲者,以前手动找得花几周,现在几分钟就能出短名单。更有意思的是,他们整合了Model Context Protocol(MCP),用户可以直接在Claude或者ChatGPT里跟SpeakUp互动,用自然语言描述需要的演讲者,就能拿到推荐、联系帮助和预订支持,不用再翻数据库或者找中介。 商业模式上,SpeakUp也打破了传统。传统演讲经纪公司靠佣金吃饭,SpeakUp用订阅制,演讲者能保留全部预订费用,两边还能直接对接。 这事儿背后其实是AI原生企业的崛起。第一波AI应用是在现有组织上叠加工具,比如用ChatGPT写文案。但下一波,可能是直接重新设计组织——让AI成为核心操作系统。市场平台尤其容易被影响,因为它们的核心价值链就是匹配、沟通、资格审核、调度这些AI擅长的事儿。未来几年,可能会有更多平台缩小人类团队,让AI agent处理更复杂的运营。当然,不是所有AI原生公司都能成,但SpeakUp的尝试至少让我们看到:AI不再只是工具,它能成为公司本身的一部分。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

裁掉全部运营团队全交AI管 这个撮合平台跑通了行业新范本

By: Alex Mercer,硅谷科技总监&行业极客分析师 我前阵子和伦敦市场策略师Ethan Caldwell聊过。他做了15年SaaS和平台企业咨询,话很直接。多数创业公司用AI只是给员工提效,SpeakUp的逻辑完全不一样。他们把AI当整个公司用,而不是一个功能插件。现在没人纠结AI会不会写邮件排会议。大家要看的是AI代理网络,能不能替代传统部门跑通全流程。 SpeakUp是连接会议主办方、播客主、品牌、媒体和演讲者的撮合平台。2025年才公开发布,仅一年用户就突破10万,覆盖28个国家9种语言。平台现在部署了31个专属AI代理,覆盖外呼销售、用户入驻、客服、内容创作、平台管理、全生命周期营销所有环节。传统要几周的人工对接筛选,现在AI几分钟就能出匹配短名单。 很多人没注意到它的Model Context Protocol接入能力。用户直接在Claude、ChatGPT这类AI助手里面就能调用服务。你用自然语言描述要什么样的演讲者,它直接给推荐、做对接、搞定预订,不用翻数据库找中介。传统演讲经纪靠佣金抽成吃饭,它走订阅模式,演讲者能拿全额预订费,供需双方直接对接。这直接动了传统中介的核心利益。 接下来所有靠撮合、对接、调度生存的平台,都会先被AI原生模式冲垮,别抱着传统人头团队的老路子耗了。
More

数字标牌的暗战:安全审计为何成了厂商的生死线?

(SeaPRwire) - Li Ming,一位深耕企业端点安全领域18年的资深顾问,最近在一次行业沙龙上抛出了一个尖锐观点:“数字标牌早不是被动的显示工具了。现在的网络连接着云端和内部系统,每一块屏幕都是潜在的攻击入口。很多企业还在只盯着软件层的安全,却忽略了固件和硬件这些容易被突破的环节。” 这种认知的转变,让最近Skykit完成的SOC 2 Type 2认证格外引人关注。作为企业级数字标牌提供商,Skykit的这次认证覆盖了整个平台生态——包括Beam内容管理系统、Control设备管理软件、媒体播放器固件以及硬件相关组件。和一次性合规检查不同,SOC 2 Type 2认证由美国注册会计师协会(AICPA)标准下的第三方独立机构执行,它会在一段持续时间内跟踪安全控制措施的实际运行情况,确保这些措施不是停留在纸面上的政策,而是真正有效的长期保障。 对于医疗、制造、零售等受监管行业来说,这一点尤为重要。这些行业越来越依赖数字标牌网络分发关键运营数据和业务通信,设备管理系统、固件或云端基础设施的任何漏洞都可能引发大范围的运营风险。Skykit方面表示,此次审计涵盖了访问管理、加密实践、事件响应流程和持续监控能力等多个维度,结果证明这些控制措施在观察期内始终保持活跃且有效。 数字标牌行业正在进入一个新的竞争阶段。过去比拼的是显示效果和内容管理功能,现在则转向了“端到端的运营信任”。能够证明自身在云端服务、设备、固件和网络基础设施全链条安全的厂商,将在采购团队日益严格的标准下占据优势。安全审计已经从合规性的“checkbox”变成了战略差异化的工具,它不再只是满足要求的手段,而是衡量长期可靠性的重要指标。对于企业来说,这意味着选择标牌供应商时,安全能力将和功能体验一样重要;对于厂商来说,持续的安全验证将成为生存和发展的关键。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

数字标牌安全审计:为何成了新战场?

By: 罗伯特·斯特林,资深行业专家 多年来,数字标牌在企业技术体系里一直默默无名。屏幕上展示着通知、仪表盘、促销内容和运营更新。以前少有人质疑这些显示屏会带来安全隐患,可现在这种想法正在迅速改变。 网络安全分析师迈克尔·哈灵顿称,企业显示网络正发生重大转变,组织开始把屏幕视为连接端点,而非被动的通信工具。他有超过20年为财富500强企业提供基础设施安全建议的经验。 哈灵顿指出:“很多公司评估数字标牌供应商的方式还和十年前一样。他们常忽略现代显示网络会处理数据、连接云平台、与内部系统交互,且在数千个地点运行。安全问题不能只停留在软件层面,每个设备、固件组件和管理系统都可能成为攻击目标。” 这就能解释为何行业内近期的安全验证工作备受关注。企业扩大连接基础设施时,要求供应商能长期保持安全运营,而不只是通过一次性合规检查。 比如Skykit,一家企业数字标牌供应商,最近完成了涵盖整个平台生态系统的SOC 2 Type 2认证。与主要关注云应用的评估不同,这次审查涉及了广泛的运营组件,包括公司的Beam内容管理平台、Control设备管理软件、媒体播放器固件及硬件相关元素。 该认证由独立第三方审计机构依据美国注册会计师协会(AICPA)制定的标准进行。SOC 2 Type 2审查并非只在某一时刻评估安全控制,而是考察这些控制在较长观察期内的运行情况,以了解组织安全实践的一致性。 对企业客户,尤其是处于高度监管行业的客户来说,这种区别很重要。制造集团、医疗供应商、零售商、教育机构和大型企业组织越来越依赖数字显示网络在多个地点分发运营数据和关键业务通信。设备管理系统、固件或云基础设施中的任何弱点都可能带来更大运营风险。 Skykit领导层认为,对软件、固件和硬件层进行全面验证反映了当今企业环境的现实。公司称审计评估了访问管理、加密实践、事件响应程序和持续监控能力等领域。结果提供了独立验证,表明这些控制长期有效,而非仅存在于书面政策中。 未来,数字标牌行业似乎将进入新阶段,安全认证可能会和显示质量或内容管理功能一样重要。企业连接的屏幕更多,收集的运营数据更多,且将标牌系统更深入地融入业务流程中。这一趋势自然提高了对治理、风险管理和合规的期望。 这个市场的下一代竞争可能不再围绕谁能提供最引人注目的展示体验。相反,可能取决于哪家供应商能展现端到端的运营信任。随着采购团队采用越来越严格的标准,能够在云服务、设备、固件和网络基础设施方面验证安全性的供应商可能会获得优势。 从这个意义上说,安全审计正从合规活动演变为战略差异化因素。曾经作为勾选项的要求正成为长期可靠性的可衡量指标,企业对此密切关注。
More
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion ACN Newswire

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

HONG KONG, Jun 4, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreement with Travere Therapeutics, Inc. (NASDAQ: TVTX) for the development and commercialization of civorebrutinib (also known as EVER001), a potential best-in-class oral, covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor in all markets outside China and certain countries in East and Southeast Asia.Under the terms of the agreement, Everest will receive an upfront payment of $112.5 million. Everest is also eligible to receive up to approximately $1.03 billion in additional cash payments tied to specified clinical development, regulatory and commercial milestones across up to five indications. Travere will also pay tiered royalties on future sales in its licensed territories, ranging from high single-digit to double-digit percentages based on annual net sales thresholds. The license agreement will become effective upon satisfaction of customary conditions, including expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.Travere Therapeutics, is a Nasdaq-listed US biopharmaceutical company (NASDAQ: TVTX) with a focus on the field of rare glomerular diseases, particularly targeting IgA nephropathy and focal segmental glomerulosclerosis (FSGS). The company is also developing therapeutic programs for rare genetic metabolic diseases, such as homocystinuria (HCU). Its core product, FILSPARI®(sparsentan) is the first and only medicine approved by the FDA for the treatment of FSGS, further strengthening the company’s leading position in the renal therapy sector.Civorebrutinib has the potential to serve as a pipeline-in-a-product across multiple immune-mediated kidney diseases. As an investigational oral, covalent reversible BTK inhibitor, civorebrutinib is designed to provide differentiated efficacy, safety and convenience for patients with rare, immune-mediated kidney disease. Driven by strong clinical development capabilities, Everest Medicines has recently achieved several key milestones in global multi-center trials, in-house R&D pipeline validation, and international licensing partnerships. Civorebrutinib has demonstrated proof of concept in a Phase 1/2 clinical trial of patients with PMN. The previously reported Phase 1/2 data demonstrated rapid and sustained reductions in anti-PLA2R autoantibodies and proteinuria, with high rates of immunologic and clinical remission and stable kidney function through 52 weeks of follow-up. EVER001 possesses therapeutic development potential in multiple immune-mediated glomerular diseases, including PMN, IgA nephropathy, MCD, FSGS, and lupus nephritis. These diseases share immune-mediated mechanisms that can lead to glomerular damage, resulting in proteinuria and impaired kidney function that may ultimately require dialysis or transplant. EVER001 is expected to offer a new treatment option for more than 10 million affected patients globally. Travere plans to investigate civorebrutinib in PMN, immune-mediated FSGS and MCD, with the potential for additional indications. “This collaboration with Travere brings together deep expertise in kidney disease development and commercialization and we look forward to advancing civorebrutinib in primary membranous nephropathy, immune-mediated FSGS, and minimal change disease, delivering transformative therapies for patients with serious kidney diseases worldwide,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “As a differentiated, potential best-in-class therapy, civorebrutinib has demonstrated encouraging efficacy in primary membranous nephropathy. With its highly selective and reversible covalent mechanism of action, it is well positioned to advance in development across multiple immune-mediated kidney indications. Everest remains committed to our dual-engine strategy of business development partnerships and in-house R&D. This collaboration will accelerate the global development and potential commercialization of civorebrutinib, expanding its clinical and future commercial value in autoimmune kidney diseases and the ability to deliver more innovative treatment options to patients.”“Civorebrutinib represents a strategic and complementary addition to our rare kidney disease portfolio, with the potential to become a best-in-class therapy across multiple immune-mediated rare kidney diseases,” said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. “Patients living with rare kidney diseases still face significant unmet need, and we believe the progress made to date in IgAN and FSGS is only the beginning of what is possible for these communities. Travere has helped to deliver important firsts in these diseases, and we believe our expertise, infrastructure and deep commitment to the rare kidney community position us well to continue advancing innovation for patients. With proof-of-concept data in primary membranous nephropathy, a differentiated profile as an oral, reversible BTK inhibitor, and expected broad mechanistic applicability across diseases such as immune-mediated FSGS, minimal change disease and beyond, we believe civorebrutinib has the potential to meaningfully advance the treatment paradigm for rare kidney disease patients.”This cooperation between Everest Medicines and Travere Therapeutics further propels the globalization of EVER001, reflecting the continued unlocking of the value of Everest Medicines innovative drugs. Currently, Everest Medicines has established a comprehensive renal product matrix inclding Nefecon®, MT1013, and EVER001, spanning indications such as IgA nephropathy, secondary hyperparathyroidism (SHPT), and a wide range of immune-mediated kidney diseases. By continuously deepening its strategic layout in nephrology, Everest Medicines is accelerating its global footprint to provide accessible and reliable treatment solutions for more patients through innovative therapies. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More